Veterinary/Warning Letter·FDA Warning Letters

Warning Letter — Tex-Stein Dairy

MediumPublished Aug 11, 2026· AI-analyzed Aug 11, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

The FDA issued a warning letter to Tex-Stein Dairy following an inspection by the Center for Veterinary Medicine. The letter indicates regulatory violations regarding the handling or administration of veterinary products at the facility.

Who it affects

Dairy producers, livestock owners, and quality management personnel responsible for animal health and food safety compliance at dairy facilities.

Why it matters

This enforcement action indicates that the FDA is monitoring dairy operations for compliance with veterinary medicine standards. Failure to adhere to these regulations suggests potential gaps in drug administration oversight or residue control, which can lead to products being deemed adulterated under the FD&C Act.

Practical takeaway

Review and document all veterinary drug administration protocols to ensure compliance with label instructions. Establish rigorous residue testing and holding period verification for livestock intended for human consumption to prevent adulteration.

FDA source material

FDA Warning Letter issued to: Tex-Stein Dairy. 06/16/2026 — Center for Veterinary Medicine. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tex-stein-dairy-728755-06162026

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.